This information was published on 2024-12-19T04:23:10 for IP Right Filed Published.
| Field | Value |
| (210) | 2508443 (IR 1829679) |
| (220) |
02 Oct 2024
|
| (300) |
US, 05 Apr 2024, 98486779
|
| (511) (510) |
Class 5
Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders; none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis. |
| (540) | ATARA |
| (550) | Word |
| (730) |
Atara Biotherapeutics, Inc.
|
Find out more about publications on the About page.